Type‐II IFN inhibits SARS‐CoV‐2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3‐dioxygenase‐mediated pathways
Dong Yang(Yancheng Central Blood Station), Hin Chu(HKU-Pasteur Research Pole), Yao‐Wei Huang(Zhejiang University), Chaemin Yoon(University of Hong Kong), Yue Chai(Chinese University of Hong Kong), Shuofeng Yuan(University of Hong Kong), Tianrenzheng Zhu(University of Hong Kong), Bingjie Hu(Wenzhou Medical University), Huiping Shuai(Chinese University of Hong Kong), Jasper Fuk‐Woo Chan(Hong Kong Baptist University), Jinxia Zhang(Peking University), Xiner Huang(University of Hong Kong), Yuxin Hou(University of Hong Kong), Tsz‐Yat Luk(Chinese University of Hong Kong), Yuanchen Liu(University of Hong Kong), Jialu Shi(University of Hong Kong), Yang Wang(University of Science and Technology of China), Yixin He(University of Hong Kong), Bao‐Zhong Zhang(Daqing Oilfield General Hospital), Huan Liu(University of Hong Kong), Terrence Tsz‐Tai Yuen(Sichuan University), Wing‐Kuk Au(Queen Mary Hospital), Ko‐Yung Sit(Queen Mary Hospital)
Cited by 4
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k